About this trial
The aim of the study is to investigate the effects of an upper limb cycle ergometer in phase I CABG patients. This will likely enhance various outcomes such as quality of life, dyspnea, functional outcome measure, cardiovascular parameters, and upper limb mobility. If utilized, the arm ergometer may contribute to improve upper limb strength and endurance. This could result in improving upper limb range of motion and reducing the risk of adhesive capsulitis. This study will positively impact society by reducing morbidity and mortality rates, healthcare costs and ultimately improves patient care.
Eligibility criteria
Qualifiers
Planned CABG patients
40-65 years
Both male and female
Hemodynamic stable patients
Disqualifiers
Patients suffering from pulmonary diseases and thyroid disorders
Mechanical ventilation more than 24 hr
Mean arterial pressure i.e, < 60 mmHg or > 140 mmHg and heart rate not more than 120bpm
Having an orthopedic condition that makes the use of upper and lower extremity impossible.
Trial design
Treatments tested in this trial
- upper limb exercise with arm ergometer
- upper limb exercise with out arm ergometer